Evidence map›Paper›PMID 28894177›Full record

ArticleNature microbiology2017

A viral protein antibiotic inhibits lipid II flippase activity.

Karthik R Chamakura, Lok-To Sham, Rebecca M Davis, Lorna Min, Hongbaek Cho, Natividad Ruiz, Thomas G Bernhardt, Ry Young

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. ssRNA bacteriophage metagenomes reveal a diverse set of novel protein families.Protein science : a publication of the Protein Society · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Phage lysis protein LysScience advances · 2025
    Article
  7. Article
  8. Article
  9. Physiological characterization of single gene lysis proteins.bioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Article
  12. Assembly of Bacterial Surface Glycopolymers as an Antibiotic Target.Journal of microbiology (Seoul, Korea) · 2023
    Review
  13. Structure and Mechanism of the Lipid Flippase MurJ.Annual review of biochemistry · 2022
    Review
  14. Review
  15. Article
  16. Natural products that target the cell envelope.Current opinion in microbiology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Single-gene lysis in the metagenomic era.Current opinion in microbiology · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Karthik R ChamakuraCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M AgriLife Research, Texas A&M University, College Station, TX, 77843-2128, USA.ORCID http://orcid.org/0000-0002-6196-8571
Lok-To ShamDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02215, USA.
Rebecca M DavisDepartment of Microbiology, Ohio State University, Columbus, OH, 43210, USA.
Lorna MinCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M AgriLife Research, Texas A&M University, College Station, TX, 77843-2128, USA.
Hongbaek ChoDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02215, USA.
Natividad RuizDepartment of Microbiology, Ohio State University, Columbus, OH, 43210, USA.
Thomas G BernhardtDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02215, USA. thomas@hms.harvard.edu.ORCID http://orcid.org/0000-0003-3566-7756
Ry YoungCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M AgriLife Research, Texas A&M University, College Station, TX, 77843-2128, USA. ryland@tamu.edu.ORCID http://orcid.org/0000-0001-8001-2914
Harvard University · USTexas A&M University System · USThe Ohio State University · US

Funding

Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI BELTZ, GERALD A · 2014 to 2018
$25.2M
CONTROL OF VIRUS-INDUCED LYSISR01GM027099 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI YOUNG, RYLAND FLETCHER · 1985 to 2019
$4.6M
Identifying and validating new antibiotic targets in cell wall synthesis pathwaysR01AI099144 · NIAID · HARVARD MEDICAL SCHOOL · PI BERNHARDT, THOMAS G, WALKER, SUZANNE · 2012 to 2016
$4.3M
Envelope Biogenesis in Gram-negative BacteriaR01GM100951 · NIGMS · OHIO STATE UNIVERSITY · PI RUIZ, NATIVIDAD · 2012 to 2023
$3.7M
CONTROL OF VIRUS INDUCED LYSISR37GM027099 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI YOUNG, RYLAND F. · 1996 to 2005
$2.4M
NIAID NIH HHS R01 AI099144NIAID NIH HHS U19 AI109764NIGMS NIH HHS R01 GM027099NIGMS NIH HHS R01 GM100951NIGMS NIH HHS R37 GM027099
6 · The paper itself

Abstract

For bacteriophage infections, the cell walls of bacteria, consisting of a single highly polymeric molecule of peptidoglycan (PG), pose a major problem for the release of progeny virions. Phage lysis proteins that overcome this barrier can point the way to new antibacterial strategies

Indexed as

Anti-Bacterial AgentsBacteriolysisCell MembraneCell WallEscherichia coliEscherichia coli ProteinsLevivirusPeptidoglycanPhospholipid Transfer ProteinsProtein ConformationUridine Diphosphate N-Acetylmuramic AcidViral ProteinsVirionAnti-Bacterial AgentsEscherichia coli Proteinsmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolMurJ protein, E coliPeptidoglycanPhospholipid Transfer ProteinsUridine Diphosphate N-Acetylmuramic AcidViral Proteins

Identifiers

PMID28894177
PMCPMC5764540
OpenAlexW2752211880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.